Voyager Therapeutics, Inc. - 8-K Filing
Voyager Therapeutics reports Q3 2026 results with $132.1 million cash position providing runway into Q2 2028
Tickers: $VYGR
Voyager Therapeutics reports Q3 2026 results with $132.1 million cash position providing runway into Q2 2028
Tickers: $VYGR